Supporting this hypothesis, an analysis of the amount of methylated CAHM in DNA extracted from plasma relative to CRC staging showed that increasing levels of methylated CAHM correlated with advancing disease stage in these limited data (Fig. 5). The gene discussed is CAHM; the disease is colorectal carcinoma.